Healthcare Professionals
Prix Galien
Hexacath France received the Prix Galien 2021 in the “Medical Device” category with TiTAN OPTiMAX indicated in the treatment of coronary syndromes
Pre-Clinical
Experience
Before committing to the development of new technologies, Hexacath relied on a large body of pre-clinical evidence and fundamental in vitro and in vivo studies.
Clinical Evidence
Over almost 2 decades have been necessary to gather an impressive amount of clinical evidence demonstrating the Titan bioactive stent Superiority in ACS drug-eluting stent in Acute Coronary Syndrome patients and the interest of the continuous thermodilution technology using the RayFlow microcatheter to assess Coronary Microvascular Disease.
Explore our locations
around the world
FRANCE
- France
- Italy
- Spain
- Netherlands
- Belgium
- Switzerland
- Serbia
- Bosnia
- Finland
MIDDLE EAST
- Israël
Saudi Arabia (in progress)
AMERICA
- USA
Mexico
ASIA
- India
Japan (in progress)
Vietnam
South Korea
Taiwan - Hong Kong
Singapore (in progress) - Indonesia
- Malaysia
- Pakistan (in progress)
- Thailand (in progress)